vbi-1901
vbi vaccines
['gbm']
$vbiv vbi vaccines presents updated phase 2a tumor response and overall survival data for vbi-1901 in recurrent gbm at the 2022 asco annual meeting 
This is an automated account sharing new press releases in real time from https://t.co/7iCFuj68H6